ACADIA PHARMACEUTICALS INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ACADIA PHARMACEUTICALS INC. (ACAD) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 161.23 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-05
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 161.23M shares, a 0.76% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 163.02M shares, a 2.35% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 160.66M shares, a 1.60% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 160.42M shares, a 2.48% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 160.49M shares, a 2.01% increase from fiscal 2020.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 157.33M shares, a 6.88% increase from fiscal 2019.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 147.20M shares, a 16.29% increase from fiscal 2018.
- ACADIA PHARMACEUTICALS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 126.58M shares, a 3.25% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 161.23M shares 10-Q · filed 2022-05-05 | 162.13M shares derived: average of 2 quarters · filed 2022-05-05 | 161.64M shares derived: average of 3 quarters · filed 2022-05-05 | 161.33M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 163.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 161.84M shares derived: average of 2 quarters · filed 2022-03-01 | 161.37M shares derived: average of 3 quarters · filed 2022-03-01 | 160.49M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 160.66M shares 10-Q · filed 2021-11-09 | 160.54M shares derived: average of 2 quarters · filed 2021-11-09 | 159.65M shares 10-Q · filed 2021-11-09 | 160.09M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-06-30 | 160.42M shares 10-Q · filed 2021-08-05 | 160.22M shares 10-Q · filed 2021-08-05 | 159.90M shares derived: average of 3 quarters · filed 2022-05-05 | 159.46M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-03-31 | 160.01M shares 10-Q · filed 2022-05-05 | 159.64M shares derived: average of 2 quarters · filed 2022-05-05 | 159.14M shares derived: average of 3 quarters · filed 2022-05-05 | 158.49M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 159.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 158.70M shares derived: average of 2 quarters · filed 2022-03-01 | 157.98M shares derived: average of 3 quarters · filed 2022-03-01 | 157.33M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 158.13M shares 10-Q · filed 2021-11-09 | 157.33M shares derived: average of 2 quarters · filed 2021-11-09 | 156.68M shares 10-Q · filed 2021-11-09 | 156.15M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 156.53M shares 10-Q · filed 2021-08-05 | 155.95M shares 10-Q · filed 2021-08-05 | 155.49M shares derived: average of 3 quarters · filed 2022-03-01 | 153.10M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 155.37M shares 10-Q · filed 2021-05-06 | 154.97M shares derived: average of 2 quarters · filed 2022-03-01 | 151.95M shares derived: average of 3 quarters · filed 2022-03-01 | 150.04M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | 154.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 150.24M shares derived: average of 2 quarters · filed 2022-03-01 | 148.26M shares derived: average of 3 quarters · filed 2022-03-01 | 147.20M shares 10-K · filed 2022-03-01 |
| 2019-09-30 | 145.91M shares 10-Q · filed 2020-11-04 | 145.11M shares derived: average of 2 quarters · filed 2020-11-04 | 144.74M shares 10-Q · filed 2020-11-04 | 141.47M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | 144.31M shares 10-Q · filed 2020-08-06 | 144.15M shares 10-Q · filed 2020-08-06 | 139.99M shares derived: average of 3 quarters · filed 2021-02-25 | 136.25M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | 143.98M shares 10-Q · filed 2020-05-08 | 137.83M shares derived: average of 2 quarters · filed 2021-02-25 | 133.56M shares derived: average of 3 quarters · filed 2021-02-25 | 131.40M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | 131.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 128.35M shares derived: average of 2 quarters · filed 2021-02-25 | 127.20M shares derived: average of 3 quarters · filed 2021-02-25 | 126.58M shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 125.01M shares 10-Q · filed 2019-10-31 | 124.96M shares derived: average of 2 quarters · filed 2019-10-31 | 124.88M shares 10-Q · filed 2019-10-31 | 124.69M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | 124.91M shares 10-Q · filed 2019-08-01 | 124.82M shares 10-Q · filed 2019-08-01 | 124.59M shares derived: average of 3 quarters · filed 2020-02-27 | 124.06M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | 124.73M shares 10-Q · filed 2019-05-02 | 124.43M shares derived: average of 2 quarters · filed 2020-02-27 | 123.78M shares derived: average of 3 quarters · filed 2020-02-27 | 123.37M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | 124.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 123.31M shares derived: average of 2 quarters · filed 2020-02-27 | 122.91M shares derived: average of 3 quarters · filed 2020-02-27 | 122.60M shares 10-K · filed 2020-02-27 |
| 2017-09-30 | 122.48M shares 10-Q · filed 2018-11-06 | 122.30M shares derived: average of 2 quarters · filed 2018-11-06 | 122.09M shares 10-Q · filed 2018-11-06 | 121.88M shares derived: average of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | 122.12M shares 10-Q · filed 2018-08-08 | 121.89M shares 10-Q · filed 2018-08-08 | 121.67M shares derived: average of 3 quarters · filed 2019-02-27 | 120.63M shares derived: average of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | 121.65M shares 10-Q · filed 2018-05-04 | 121.45M shares derived: average of 2 quarters · filed 2019-02-27 | 120.13M shares derived: average of 3 quarters · filed 2019-02-27 | 118.42M shares derived: average of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | 121.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 119.37M shares derived: average of 2 quarters · filed 2019-02-27 | 117.35M shares derived: average of 3 quarters · filed 2019-02-27 | 115.86M shares 10-K · filed 2019-02-27 |
| 2016-09-30 | 117.50M shares 10-Q · filed 2017-11-07 | 115.40M shares derived: average of 2 quarters · filed 2017-11-07 | 114.06M shares 10-Q · filed 2017-11-07 | 110.84M shares derived: average of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | 113.31M shares 10-Q · filed 2017-08-08 | 112.33M shares 10-Q · filed 2017-08-08 | 108.62M shares derived: average of 3 quarters · filed 2018-02-27 | 106.66M shares derived: average of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | 111.35M shares 10-Q · filed 2017-05-09 | 106.28M shares derived: average of 2 quarters · filed 2018-02-27 | 104.44M shares derived: average of 3 quarters · filed 2018-02-27 | 103.42M shares derived: average of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | 101.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 100.98M shares derived: average of 2 quarters · filed 2018-02-27 | 100.77M shares derived: average of 3 quarters · filed 2018-02-27 | 100.63M shares 10-K · filed 2018-02-27 |
| 2015-09-30 | 100.76M shares 10-Q · filed 2016-11-07 | 100.55M shares derived: average of 2 quarters · filed 2016-11-07 | 100.44M shares 10-Q · filed 2016-11-07 | 99.67M shares derived: average of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | 100.35M shares 10-Q · filed 2016-08-04 | 100.27M shares 10-Q · filed 2016-08-04 | 99.30M shares derived: average of 3 quarters · filed 2017-02-28 | 99.35M shares derived: average of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | 100.20M shares 10-Q · filed 2016-05-05 | 98.78M shares derived: average of 2 quarters · filed 2017-02-28 | 99.02M shares derived: average of 3 quarters · filed 2017-02-28 | 99.03M shares derived: average of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | 97.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 98.43M shares derived: average of 2 quarters · filed 2017-02-28 | 98.64M shares derived: average of 3 quarters · filed 2017-02-28 | 97.25M shares 10-K · filed 2017-02-28 |
| 2014-09-30 | 99.50M shares 10-Q · filed 2015-11-05 | 99.27M shares derived: average of 2 quarters · filed 2015-11-05 | 97.21M shares 10-Q · filed 2015-11-05 | 95.63M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | 99.05M shares 10-Q · filed 2015-08-06 | 96.04M shares 10-Q · filed 2015-08-06 | 94.35M shares derived: average of 3 quarters · filed 2016-02-29 | 93.14M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | 92.97M shares 10-Q · filed 2015-05-07 | 92.00M shares derived: average of 2 quarters · filed 2016-02-29 | 91.16M shares derived: average of 3 quarters · filed 2016-02-29 | 89.23M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | 91.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 90.26M shares derived: average of 2 quarters · filed 2016-02-29 | 87.98M shares derived: average of 3 quarters · filed 2016-02-29 | 85.72M shares 10-K · filed 2016-02-29 |
| 2013-09-30 | 89.50M shares 10-Q · filed 2014-11-10 | 86.46M shares derived: average of 2 quarters · filed 2014-11-10 | 83.95M shares 10-Q · filed 2014-11-10 | 78.08M shares derived: average of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | 83.41M shares 10-Q · filed 2014-08-05 | 81.11M shares 10-Q · filed 2014-08-05 | 74.28M shares derived: average of 3 quarters · filed 2015-02-26 | 69.19M shares derived: average of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | 78.75M shares 10-Q · filed 2014-05-06 | 69.71M shares derived: average of 2 quarters · filed 2015-02-26 | 64.45M shares derived: average of 3 quarters · filed 2015-02-26 | 61.57M shares derived: average of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | 60.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | 57.29M shares derived: average of 2 quarters · filed 2015-02-26 | 55.85M shares derived: average of 3 quarters · filed 2015-02-26 | 55.12M shares 10-K · filed 2015-02-26 |
| 2012-09-30 | 53.91M shares 10-Q · filed 2013-11-06 | 53.44M shares derived: average of 2 quarters · filed 2013-11-06 | 53.26M shares 10-Q · filed 2013-11-06 | 53.15M shares derived: average of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | 52.96M shares 10-Q · filed 2013-08-06 | 52.93M shares 10-Q · filed 2013-08-06 | 52.90M shares derived: average of 3 quarters · filed 2014-02-27 | 52.88M shares derived: average of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | 52.90M shares 10-Q · filed 2013-05-07 | 52.87M shares derived: average of 2 quarters · filed 2014-02-27 | 52.85M shares derived: average of 3 quarters · filed 2014-02-27 | 52.81M shares derived: average of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | 52.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | 52.82M shares derived: average of 2 quarters · filed 2014-02-27 | 52.77M shares derived: average of 3 quarters · filed 2014-02-27 | 52.18M shares 10-K · filed 2014-02-27 |
| 2011-09-30 | 52.80M shares 10-Q · filed 2012-11-05 | 52.74M shares derived: average of 2 quarters · filed 2012-11-05 | 51.96M shares 10-Q · filed 2012-11-05 | |
| 2011-06-30 | 52.68M shares 10-Q · filed 2012-08-08 | 51.53M shares 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |